Ophthalmology · San Antonio, TX
NPI
1427286137
Since 2009
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
800 McCullough Ave
San Antonio, TX, 78215
Phone (210) 226-6169
Groups this clinician bills Medicare through
Medicare paid, 2024
$439K
3,898 services
Medicare patients, 2024
255
Average age 73
Drug cost, 2024
$1.3M
1,251 prescriptions
Company payments, 2025
$2,302
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Gawain Dyer was code 92014 (ophthalmological e&m), 461 times for 232 patients. In total Gawain Dyer billed 3,898 services in 28 codes, and Medicare paid $439K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-08-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92014 Ophthalmological E&M | Office | 461 | 232 | $84.09 | $39K |
| 92134 Computerized Ophthalmic Imaging | Office | 459 | 228 | $28.37 | $13K |
| 67028 Intravitreal Injection | Office | 343 | 85 | $86.98 | $30K |
| J0178 Injection, aflibercept, 1 mg | Office | 308 | 28 | $657.41 | $202K |
| J9035 Injection, bevacizumab, 10 mg | Office | 157 | 43 | $55.35 | $8,690 |
| J7312 Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 126 | 13 | $161.18 | $20K |
| 67228 Eye | Office | 29 | 15 | $252.91 | $7,334 |
By year: 2022 $472K for 2,305 services; 2023 $386K for 2,419 services; 2024 $439K for 3,898 services.
Medicare prescription drug claims, 2024
In 2024, the drug Gawain Dyer prescribed most often to Medicare patients was Eylea (Aflibercept), with 375 prescriptions and refills. In total Gawain Dyer wrote 1,251 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eylea Aflibercept | 375 | 529 | 98 | $873K |
| Prednisolone Acetate Generic | 131 | 171 | 96 | $5,301 |
| Latanoprost Generic | 104 | 186 | 43 | $1,064 |
| Erythromycin Erythromycin Base | 98 | 99 | 59 | $1,164 |
| Vabysmo Faricimab-Svoa | 72 | 75 | 16 | $186K |
| Timolol Maleate Generic | 71 | 147 | 28 | $1,138 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 45 | 113 | 18 | $717 |
| Brimonidine Tartrate Generic | 42 | 87 | 20 | $1,110 |
| Eylea Hd Aflibercept | 42 | 50 | Under 11 | $126K |
| Dorzolamide Hcl Generic | 41 | 78 | 21 | $925 |
| Moxifloxacin Moxifloxacin Hcl | 27 | 27 | 27 | $1,088 |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 26 | 38 | 13 | $2,965 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 20 | 20 | 16 | $267 |
| Ozurdex Dexamethasone | 18 | 20 | 14 | $27K |
| Lucentis Ranibizumab | 18 | 33 | Under 11 | $35K |
Brand drugs: 745 claims; generic drugs: 506 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Gawain Dyer $2,302 ($931 in general payments such as food, travel and fees and $1,371 for research) from 10 companies. The largest payer was Regeneron Pharmaceuticals, Inc. with $1,371.
| Company | Payments | Amount |
|---|---|---|
| Regeneron Pharmaceuticals, Inc. REGN | 7 | $1,371 |
| Harrow Eye, LLC | 4 | $226 |
| ANI Pharmaceuticals, Inc. ANIP | 5 | $214 |
| Abbvie Inc. ABBV | 5 | $122 |
| Genentech, Inc. ROG.SW | 1 | $112 |
| Astellas Pharma US Inc 4503.T | 5 | $105 |
| Regeneron Healthcare Solutions, Inc. REGN | 4 | $91.61 |
| Amgen Inc. AMGN | 1 | $23.16 |
| Genentech USA, Inc. ROG.SW | 1 | $22.41 |
| Mallinckrodt Hospital Products Inc. | 1 | $14.18 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.